NAME Dr. George Sharbeen
CANCER TYPE Pancreatic cancer
INSTITUTION University of New South Wales
STATE New South Wales
GRANT TYPE $80,000

"Pancreatic cancer is a devastating disease with only 7% of patients surviving 5 years after diagnosis. This project will use a novel nanoparticle to inhibit a key tumour-promoting gene in pancreatic tumours. The findings from this work could eventually be translated into a more effective treatment for pancreatic cancer."

Dr. George Sharbeen, researcher for the University of New South Wales.